Table 3.
Indication for the reversal of warfarin effects with FEIBA and FFP
| Indication | FEIBA n = 72 | FFP n = 69 | ||||
|---|---|---|---|---|---|---|
| INR <5 | INR ≥5 | Total | INR <5 | INR ≥5 | Total | |
| GI bleeding | 18.4%(9) | 34.8%(8) | 23.6%(17) | 24.1%(13) | 33.3%(5) | 26.1%(18) |
| Intracranial hemorrhage | 46.9%(23) | 21.7%(5) | 38.9%(28) | 9.3% (5) | 26.7%(4) | 13.0% (9) |
| Preoperative | 18.4%(9) | 4.3%(1) | 13.9%(10) | 46.3%(25) | 6/7%(1) | 37.8%(26) |
| Other | 16.3%(8) | 39.1%(9) | 23.6%(17) | 20.4%(11) | 33.3%(5) | 23.2%(16) |
| Total | 100%(49) | 100%(23) | 100%(72) | 100% (54) | 100%(15) | 100% (69) |
P = 0.025 using chi-square with 3 degrees of freedom comparing the FEIBA group with the FFP group subdivided by indication